Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Florence Coste (Bordeaux, France), Florence Coste, Christian Toussaint, Mathilde Dubois, Arnaud Courtois, Christelle Guibert, Roger Marthan, Jean-Pierre Savineau, Bernard Muller, Véronique Michel. Role of the TrkA receptor in experimental severe pulmonary hypertension. Eur Respir J 2015; 46: Suppl. 59, 4915

Member's Comments

No comment yet.

Related content which might interest you: Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Intact serotonin signaling is not required for the development of severe angioproliferative pulmonary hypertension in rats Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Expression and role of the nerve growth factor NGF in severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Pre-clinical evaluation of a novel and selective PI3K δ/gamma inhibitor in pulmonary fibrosis Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Characterization of a new rat model of heritable PAH Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Repeated embolization and fibrinolysis inhibition induce chronic thromboembolic pulmonary hypertension in rabbits Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014